Ice-N-Go package Ice-N-Go
Medium Med Cooler Medium
Large Med Cooler Large
X-Large Med Cooler X-Large
Navy EMT Cooler EMT
Red EMT Cooler Fire
Vaccine Cooler Vaccine
Specimen Courier Cooler Courier
Poller Roller Roller
Blue Gel Bullet Bullet
PBC Cool Vest Vest

Description



Large EMT Cooler
The Polar Bear EMT / Fire Rescue Cooler is a 12 pack size cooler with cotton duck side pockets for exterior storage. This product is currently being used by the Colorado Springs Fire Department for the use of transporting IV Fluid. EMT and Fire Rescue personnel report that administering IV Fluid that is 45 degree Fahrenheit to a patient, who is being treated for cardiac arrest, reduces the chances of brain damage. The CSFD uses this Polar Bear Cooler product because it�s light weight and durable. We maintain that this product will keep ice for 24 hours in 100-degree heat.

Rating: 5 out of 55 out of 55 out of 55 out of 55 out of 5

Add a custom monogram - $10.00

$55.00

Quantity:

Thermometer $30.00 $30.00
Ice pack $6.00 $8.00
Container $7.00 $8.00
Pre-liner 3 pack $6.00 $7.00

Specs

Warranty

Reviews

Catalog

Photos

Uses
Send a Logo
To email us a logo, click here

Customer Reviews
Average Customer Review: 5 out of 55 out of 55 out of 55 out of 55 out of 5 2 Reviews
Write an online review and share your thoughts with others.
5 out of 55 out of 55 out of 55 out of 55 out of 5 Great Cooler, even better company, 6.27.2011
Reviewer: Ken (Colorado Springs, CO )

We started therapeutic hypothermia a few years ago using electric coolers. After several models and modifications, we moved to the Polar Bear Coolers. The staff at Polar Bear was excellent to work with and very accommodating to our modification requests. The only complaint I heard after our switch to the Polar Bear coolers was that out IV solutions were too cold, which really wasn�t a problem when you�re trying to cool a patient.

 

5 out of 55 out of 55 out of 55 out of 55 out of 5 Early cooling in cardiac arrest may improve survival Abstract 13, 10.22.2010
Reviewer: Kevin (Charleston, WV)

Study highlights: In a European study, patients were more likely to survive without brain damage after a cardiac arrest if emergency medical technicians lowered their body temperature early during resuscitation. Cooling is recommended for comatose patients after cardiac arrest, and this study demonstrates the potential benefits of beginning cooling even sooner during the arrest in the pre-hospital setting. Video clip interview with Dr. Maaret Castren located at bottom of page ORLANDO, FLA., Nov. 15, 2009 – Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association’s Scientific Sessions 2009. “We now have a method that is safe and can be started within minutes of cardiac arrest to minimize damage during this very critical period,” said Maaret Castrén, M.D., lead author of the study and professor of emergency medicine at the Karolinska Institute in Stockholm. For years, people hospitalized after cardiac arrest have been cooled to reduce injury to the brain and other tissues that occurs when the blood supply returns after being temporarily halted. In the PRINCE (Pre-Resuscitation Intra-Nasal Cooling Effectiveness) investigation, Castrén and colleagues at 14 other centers across Europe used a new tool, RhinoChill, that cools the brain during ongoing cardiopulmonary resuscitation (CPR). Researchers randomized 200 adults going into witnessed cardiac arrest to receive either standard resuscitation or resuscitation with cooling started as soon as possible during the arrest, with ongoing CPR. All patients who survived to hospitalization were further cooled according to standard criteria. Eighteen patients were excluded from the analysis because a ‘do-not-resuscitate’ order was found or there was a non-cardiac reason for their cardiac arrest. In the 182 patients reported, 83 (average age 66 years, 71 percent male) were randomized to receive nasal cooling (although two were not cooled because of user or device problems) and 99 (average age 64.8, 78 percent male) received standard care. RhinoChill is a non-invasive device that introduces coolant through nasal prongs. The system is battery-powered and requires no refrigeration, making it suitable for emergency medical technicians in the field to use while a person is receiving CPR. The patients in each group were similar in their initial heart rhythms, how much time lapsed before CPR was started and whether CPR restored a pulse. The median time between arrest and the initiation of cooling was 23 minutes. On arrival at the hospital, the cooled patients’ temperatures (measured at the eardrum) were significantly lower (average 34.2ºC, 93.56ºF) than those receiving standard care (35.5ºC, 95.9ºF, p = 0.0001). In the total group: 46.7 percent of those cooled survived to hospital discharge, compared with 31 percent of those receiving standard care; 36.7 percent of those cooled were in good neurological condition on hospital discharge, compared with 21.4 percent of those receiving standard care. In the 137 patients in whom resuscitation efforts began within 10 minutes of cardiac arrest: 59.1 percent of those cooled survived to hospital discharge, compared with 29.4 percent of those receiving standard care; 45.5 percent of those cooled were neurologically intact at hospital discharge, compared with 17.6 percent of those receiving standard care (p=.01, adjusted for age, bystander CPR, ALS arrival; p=.028, unadjusted). “Our results show that the earlier you can do the cooling, the better,” Castrén said. “When resuscitation efforts were delayed, there was no significant difference in survival.” In a time analysis, patients who received a combination of early CPR started within six minutes of collapse and cooling had the best outcomes. Patients with ventricular fibrillation (VF), whose heart chambers aren’t pumping blood because they are twitching rapidly and erratically instead of fully contracting, are the subgroup of cardiac arrest patients most likely to survive. In this study, of the 56 patients who had VF: 62.5 percent of those cooled survived to hospital discharge, compared with 47.6 percent of those who received standard care; 50 percent of those cooled were neurologically intact at hospital discharge, compared to 28.6 percent of those who received standard care. “RhinoChill is easy and safe to use during a cardiac arrest outside of the hospital,” said Denise Barbut, M.D., senior author of the study and president and chairman of BeneChill, Inc., maker of the device. “Although the study was not powered to look at outcomes, there seemed to be a significant benefit on survival and neurologically intact survival, specifically in those treated within 10 minutes.” Eighteen adverse reactions were reported after the treatment, including three nosebleeds and 13 nasal discolorations. Coloring spontaneously returned to normal in all patients who survived. Serious adverse events, such as seizure or repeat cardiac arrest, occurred in seven cooled patients and 14 controls. RhinoChill has been approved for marketing in Europe and the company expects to start selling the device there in March 2010. Other authors are Per Nordberg, M.D.; Didier Desruelles, M.D.; Frank Eichwede, M.D.; Pierre Mols, M.D., Ph.D.; Leif Svensson, M.D., Ph.D.; Fabio Taccone, M.D.; Jean-Louis Vincent, M.D., Ph.D.; Hans-Jörg Busch, M.D.; Michael Vergnion, M.D.; Christian Storm, M.D.; Antonio Pesenti, M.D., Ph.D.; Fabien Guérisse, M.D.; Thomas Elste, M.D.; Markus Roessler, D.E.A.A.; Harald Fritz, M.D.; and Pieterjan Durnez, M.D. Author disclosures are on the abstract. Funding: BeneChill, Inc. ### Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding. NR09-1131 (SS09/Castrén) Note: Actual presentation time is 6:15 p.m., Sunday, Nov. 15, 2009

 

Navy Large EMT Cooler

Navy Large EMT Cooler

Med Cooler Open Med Cooler Pocket
Rollover Above images to view detail images.

We recieved this letter from the Colorado Springs Fire Department:

Thanks for all your help on this project. We have used the one case that we already had for two months now, and my crews love it. It�s holding temperatures better than anything that we�ve used before, and they haven�t destroyed it. That is a plus in the fire service. Our firefighters can break a steel bar, and not see a thing.

Once we have a final product, I�d like to get you in touch with my medical supply vendor. They specialize in finding products from smaller manufacturer for the specialized EMS market. Your product fits that profile perfectly.

Medical

Navy Large EMT Cooler
Red Extra Large EMT Cooler
Roller Bear
Vaccine Cooler
Medical Specimen Courier Cooler
Ice-N-Go Med Cooler
Blue Gel Bullet
Medium Med Cooler
Large Med Cooler
X-Large Med Cooler
PBC Cool Vest